Abstract Background and aims A stroke registry might be used to improve stroke care. The Registry of Stroke Care Quality (RES-Q) was launched by ESO-EAST (Enhancing and Accelerating Stroke Treatment) in 2016, and Croatia has been participating since 2017. The aim was to compare results captured from the RES-Q registry in Croatia for the first quarters of the last five years (2019 to 2025). Figure 1 shows the map of Croatia with all stroke centers (green— three periods, yellow—two periods, red—one period, black–no data). Methods Data on demographics, stroke care pathways, specific acute treatment issues, and stroke prevention issues in all acute stroke admissions in Croatia during the first quarters of 2019 to 2025 were analyzed. Table 1 shows the number of patients recruited by site and time period. Results Acute hospitals that provide stroke treatment recruited 5330 patients. Table 2 shows patients' main baseline characteristics and outcome measures. Conclusions Our results showed improvement in recanalization rates across Croatia (IVT from 10% to 20.6% in 2022, and mechanical thrombectomy from 4.0 to 13.9% in 2025), with a median DTN time of 39 minutes in 2021 and a DTG time of 54 minutes in 2024. Secondary stroke prevention still might be improved by increasing the usage of statins and performing smoking cessation programs. A national registry that includes all stroke centers might yield more accurate data. Conflict of interest Hrvoje Budincevic reports speaker fees: Bayer, Boehringer Ingelheim, Medis, Novartis, Sandoz, Berlin Chemie Menarini, and Pfizer. Membership on advisory councils: WSO, ESO EAST, SAP-E, Angels Initiative, participation in clinical trials: NovoNordisk, Janssen. Others: nothing to disclose Figure 1 - belongs to Background and aims Figure 2 - belongs to Methods Figure 3 - belongs to Results
Budincevic et al. (Fri,) studied this question.